Family Office Briefing on research bySavills·Aug 7, 2024
Raleigh-Durham Q2 2024 Life Sciences Market Report
Raleigh-Durham life sciences market shows robust investment activity in Q2 2024 — family offices should consider co-GP opportunities with leading developers.
Key Metrics
| Metric | Value |
|---|---|
| Capital Invested | 1.0Billion |
| Deal Count | 30None |
Metrics extracted from the source report and independently fact-checked. Method →
Full report
Savills
Building a thesis around Raleigh? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.